Understanding Fertility in Young Female Cancer Patients

Journal of Women's Health

Volumn 24, Issue 10, 2015, Pages 812-818

  Waimey, Kate E ^a   Smith, Brigid M ^b   Confino, Rafael ^b   Jeruss, Jacqueline S ^c   Pavone, Mary Ellen ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GONADORELIN AGONIST; LUTEINIZING HORMONE; MELPHALAN; METHOTREXATE; PROCARBAZINE;

ABORTION; AMENORRHEA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CHILDHOOD CANCER; CRYOPRESERVATION; EARLY MENOPAUSE; EMBRYO CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; GYNECOLOGIST; HORMONAL REGULATION; HUMAN; OOCYTE CRYOPRESERVATION; OOPHOROPEXY; OVARIAN RESERVE; OVARIAN TISSUE CRYOPRESERVATION; OVARIAN TRANSPOSITION; OVARY HYPERSTIMULATION; PATIENT REFERRAL; PREMATURE LABOR; PRIORITY JOURNAL; SPONTANEOUS ABORTION; TIMING OF PREGNANCY; ATTITUDE TO HEALTH; INFERTILITY, FEMALE; NEOPLASMS; QUALITY OF LIFE; SURVIVOR;

FEMALE; FERTILITY PRESERVATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; QUALITY OF LIFE; SURVIVORS;

EID: 84945575895     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2015.5194     Document Type: Article

References (74)

1. National Cancer Institute, Division of Cancer Control and Population Science Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) Program. U.S. population data: 1969-2013. Released January 2015. Available at www.seer.cancer.gov/popdata Accessed February 15, 2015.
2. Altekruse SF KC, Krapcho M, Neyman N, et al. (eds). SEER cancer statistics review, 1975-2007. Based on November 2009 SEER data submission, posted to the SEER web site 2010. Bethesda, MD: National Cancer Institute, 2010. Available at http://seer.cancer.gov/csr/1975-2007 Accessed February 15, 2015.
3. Odo R, Potter C. Understanding the needs of young adult cancer survivors: A clinical perspective. Oncology 2009;23: 23-27, 33.
4. Edge B, Holmes D, Makin G. Sperm banking in adolescent cancer patients. Arch Dis Child 2006;91:149-152.
5. Soliman H, Agresta SV. Current issues in adolescent and young adult cancer survivorship. Cancer Control 2008;15: 55-62.
6. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006;24:2917-2931.
7. Letourneau JM, Ebbel EE, Katz PP, et al. Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer. Cancer 2011.
8. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2013;31:2500-2510.
9. Barton SE, Najita JS, Ginsburg ES, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: A report from the Childhood Cancer Survivor Study cohort. Lancet Oncol 2013;14:873-881.
10. Fallat ME, Hutter J. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics 2008;121: e1461-1469.
11. Nekhlyudov L, Aziz NM, Lerro C, Virgo KS. Oncologists' and primary care physicians' awareness of late and longterm effects of chemotherapy: Implications for care of the growing population of survivors. J Oncol Practi 2013;10: e29-e36.
12. Rose SR, Schreiber RE, Kearney NS, et al. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab 2004;17:55-66.
13. Ogilvy-Stuart AL, Shalet SM. Effect of radiation on the human reproductive system. Environ Health Perspect 1993; 101 Suppl 2:109-116.
14. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod 2003;18:117-121.
15. Bath LE, Wallace WH, Critchley HO. Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG 2002;109:107-114.
16. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys 2005;62:738-744.
17. Critchley HO, Bath LE, Wallace WH. Radiation damage to the uterus-Review of the effects of treatment of childhood cancer. Hum Fertil (Camb). 2002;5:61-66.
18. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr 2005:64-68.
19. Norwitz ER, Stern HM, Grier H, Lee-Parritz A. Placenta percreta and uterine rupture associated with prior whole body radiation therapy. Obstet Gynecol 2001;98:929-931.
20. Reulen RC, Zeegers MP, Wallace WH, et al. Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 2009;18:2239-2247.
21. Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Am J Obstet Gynecol 2002;187:1070-1080.
22. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer 2007;110:2222-2229.
23. Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: A report from the childhood cancer survivor study. J Clin Oncol 2009;27: 2677-2685.
24. Lo Presti A, Ruvolo G, Gancitano RA, Cittadini E. Ovarian function following radiation and chemotherapy for cancer. Eur J Obstet Gynecol Reprod Biol 2004;113:S33-S40.
25. Petrek JA, Naughton MJ, Case LD, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study. J Clin Oncol 2006;24:1045-1051.
26. Sukumvanich P,Case LD,Van Zee K, et al. Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: A prospective study. Cancer 2010;116: 3102-3111.
27. Green DM, Sklar CA, Boice JD, Jr., et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: Results from the Childhood Cancer Survivor Study. J Clin Oncol 2009;27:2374-2381.
28. De Bruin ML, Huisbrink J, Hauptmann M, et al. Treatmentrelated risk factors for premature menopause following Hodgkin lymphoma. Blood 2008;111:101-108.
29. Hodgson DC, Pintilie M, Gitterman L, et al. Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol 2007;25:11-15.
30. van der Kaaij MAE, Heutte N, Meijnders P, et al. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'É tude des Lymphomes de l'Adulte Cohort Study. Journal of Clinical Oncology 2012;30:291-299.
31. Kiserud CE, Fossa A, Holte H, Fossa SD. Post-treatment parenthood in Hodgkin's lymphoma survivors. Br J Cancer 2007;96:1442-1449.
32. Larsen EC, Müller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 2003;88:5307-5314.
33. Dillon KE, Gracia CR. Pediatric and young adult patients and oncofertility. Curr Treat Options Oncol 2012;13:161-173.
34. Wallace WH. Oncofertility and preservation of reproductive capacity in children and young adults. Cancer 2011;117: 2301-2310.
35. Medicine ECotASfR. Fertility preservation and reproduction in cancer patients. Fertil Steril 2005;83:1622-1628.
36. Society for Assisted Reproductive Technology. Thawed emrbyo transfers. 2010. Available at http://apps.nccd.cdc.gov/art/Apps/NationalSummaryReport.aspx Accessed April 9, 2012.
37. Campo-Engelstein L. Addressing the three most frequently asked questions of a bioethicist in an oncofertility setting. In: Gracia C, Woodruff T, eds. Oncofertility medical practice: Clinical issues and implementation. New York: Springer, 2012:119-127.
38. Grifo JA, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: Potential fertility preservation for female cancer patients. Fertil Steril 2010;93:391-396.
39. Lucena E, Bernal DP, Lucena C, Rojas A, Moran A, Lucena A. Successful ongoing pregnancies after vitrification of oocytes. Fertil Steril 2006;85:108-111.
40. Essential elements of informed consent for elective oocyte cryopreservation: A Practice Committee opinion. Fertil Steril 2008;90:S134-135.
41. Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2004;82:993-998.
42. Noyes N, Boldt J, Nagy ZP. Oocyte cryopreservation: Is it time to remove its experimental label? J Assist Reprod Genet 2010;27:69-74.
43. Practice Committees of American Society for Reproductive Medicine. Mature oocyte cryopreservation: A guideline. Fertil Steril 2013;99:37-43.
44. von Wolff M, Donnez J, Hovatta O, et al. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy-A technique in its infancy but already successful in fertility preservation. Eur J Cancer 2009;45: 1547-1553.
45. Gracia CR, Chang J, Kondapalli L, et al. Ovarian tissue cryopreservation for fertility preservation in cancer patients: Successful establishment and feasibility of a multidisciplinary collaboration. J Assist Reprod Genet 2012;29: 495-502.
46. Donnez J, Silber S, Andersen CY, et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 2011;43:437-450.
47. Silber S, Kagawa N, Kuwayama M, Gosden R. Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril 2010;94:2191-2196.
48. Revel A, Laufer N, Ben Meir A, Lebovich M, Mitrani E. Micro-organ ovarian transplantation enables pregnancy: A case report. Hum Reprod 2011;26:1097-1103.
49. Dittrich R, Lotz L, Keck G, et al. Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 2012;97:387-390.
50. Donnez J, Dolmans M-M. Ovarian tissue freezing: Current status. Curr Opin Obstet Gynecol 2015;27:222-230.
51. Radford JA, Lieberman BA, Brison DR, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet 2001;357:1172-1175.
52. Poirot C, Abirached F, Prades M, Coussieu C, Bernaudin F, Piver P. Induction of puberty by autograft of cryopreserved ovarian tissue. Lancet 2012;379:588.
53. Anderson RA, Hindmarsh PC, Wallace WH. Induction of puberty by autograft of cryopreserved ovarian tissue in a patient previously treated for Ewing sarcoma. Eur J Cancer 2013;49:2960-2961.
54. Rosendahl M, Greve T, Andersen CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: A review of the literature. J Assist Reprod Genet 2013; 30:11-24.
55. DolmansM-M, Luyckx V, Donnez J, Andersen CY, Greve T. Risk of transferring malignant cells with transplanted frozenthawed ovarian tissue. Fertil Steril 2013;99:1514-1522.
56. Kyono K, Doshida M, Toya M, Sato Y, Akahira J, Sasano H. Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan. Fertil Steril 2010;93:2429-2430.
57. Abir R, Feinmesser M, Yaniv I, et al. Occasional involvement of the ovary in Ewing sarcoma. Hum Reprod 2010;25:1708-1712.
58. Xu J, Lawson MS, Yeoman RR, et al. Fibrin promotes development and function of macaque primary follicles during encapsulated three-dimensional culture. Hum Reprod 2013;28:2187-2200.
59. Bardo DM, Black M, Schenk K, Zaritzky MF. Location of the ovaries in girls from newborn to 18 years of age: Reconsidering ovarian shielding. Pediatr Radiol 2009;39: 253-259.
60. Ata B, Chian RC, Tan SL. Cryopreservation of oocytes and embryos for fertility preservation for female cancer patients. Best Pract Res Clin Obstet Gynaecol 2010;24:101-112.
61. Al-Talib A, Tulandi T. Ovarian transposition as a fertility preservation strategy. In: Bedaiwy MA, Rizk B, eds. Fertility preservation: Advances and controversies. New Delhi, India: JP Brothers Medical Publisher (P) Inc., 2014:54-58.
62. Kim SS, Lee JR, Jee BC, et al. Use of hormonal protection for chemotherapy-induced gonadotoxicity. Clin Obstet Gynecol 2010;53:740-752.
63. Gerber B, von Minckwitz G, Stehle H, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study. J Clin Oncol 2011;29: 2334-2341.
64. Del Mastro L, Boni L, Michelotti A, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial. JAMA 2011;306:269-276.
65. Blumenfeld Z, Katz G, Evron A. 'An ounce of prevention is worth a pound of cure': The case for and against GnRHagonist for fertility preservation. Ann Oncol 2014;25: 1719-1728.
66. Moore HC, Unger JM, Phillips K-A, et al. Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy. N Engl J Med 2015;372:923-932.
67. Del Mastro L, Ceppi M, Poggio F, et al. Gonadotropinreleasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treat Rev 2014;40:675-683.
68. Turner NH, Partridge A, Sanna G, Di Leo A, Biganzoli L. Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: The benefit remains uncertain. Ann Oncol 2013;24:2224-2235.
69. Loh JS, Maheshwari A. Anti-Mullerian hormone-Is it a crystal ball for predicting ovarian ageing? Hum Reprod 2011;26:2925-2932.
70. Azim HA, Jr., Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: A metaanalysis of 14 studies. Eur J Cancer 2011;47:74-83.
71. Ives A, Saunders C, Bulsara M, Semmens J. Pregnancy after breast cancer: Population based study. BMJ 2007;334:194.
72. Gardino SL, Russell AE, Woodruff TK. Adoption after cancer: Adoption agency attitudes and perspectives on the potential to parent post-cancer. Cancer Treat Res 2010; 156:153-170.
73. Kohler TS, Kondapalli LA, Shah A, Chan S, Woodruff TK, Brannigan RE. Results from the survey for preservation of adolescent reproduction (SPARE) study: Gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet 2011;28:269-277.
74. Quinn GP, Vadaparampil ST, Lee JH, et al. Physician referral for fertility preservation in oncology patients: A national study of practice behaviors. J Clin Oncol 2009;27: 5952-5957.